The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Medication for Diabetes Market Research Report 2025

Global Medication for Diabetes Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1917940

No of Pages : 105

Ask Your Query
Synopsis
Medication for diabetes is a broad term that refers to any drug or treatment that helps people with diabetes manage their blood sugar levels. Blood sugar levels are affected by the amount of glucose (sugar) in the blood and the action of insulin, a hormone that helps cells use glucose for energy. People with diabetes either do not produce enough insulin, or their cells do not respond well to insulin, or both. This causes high blood sugar levels, which can lead to serious complications such as heart disease, kidney failure, nerve damage, and vision loss. Medication for diabetes aims to lower blood sugar levels to a healthy range and prevent or delay these complications.
The global Medication for Diabetes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Medication for Diabetes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medication for Diabetes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Medication for Diabetes in Type 1 Diabetes Treatment is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Medication for Diabetes include Tonghua Dongbao, Gan & Lee Pharmaceuticals, Shandong Lukang Pharmaceutical, Otsuka Pharmaceutical, East China Pharmaceutical, Beilu Pharmaceutical, Furen Pharmaceutical, AstraZeneca and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Medication for Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medication for Diabetes.
Report Scope
The Medication for Diabetes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medication for Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medication for Diabetes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tonghua Dongbao
Gan & Lee Pharmaceuticals
Shandong Lukang Pharmaceutical
Otsuka Pharmaceutical
East China Pharmaceutical
Beilu Pharmaceutical
Furen Pharmaceutical
AstraZeneca
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer
Astellas Pharma
Daiichi Sankyo
Biocon
Glenmark
Bayer AG
Takeda
Sun pharma
Segment by Type
Biguanides
Sulfonylureas
Thiazolidinedione
α-Glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Insulins
Segment by Application
Type 1 Diabetes Treatment
Type 2 Diabetes Treatment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medication for Diabetes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication for Diabetes Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biguanides
1.2.3 Sulfonylureas
1.2.4 Thiazolidinedione
1.2.5 α-Glucosidase Inhibitors
1.2.6 DPP-4 Inhibitors
1.2.7 GLP-1 Receptor Agonists
1.2.8 SGLT-2 Inhibitors
1.2.9 Insulins
1.3 Market by Application
1.3.1 Global Medication for Diabetes Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Type 1 Diabetes Treatment
1.3.3 Type 2 Diabetes Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medication for Diabetes Market Perspective (2019-2030)
2.2 Medication for Diabetes Growth Trends by Region
2.2.1 Global Medication for Diabetes Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Medication for Diabetes Historic Market Size by Region (2019-2024)
2.2.3 Medication for Diabetes Forecasted Market Size by Region (2025-2030)
2.3 Medication for Diabetes Market Dynamics
2.3.1 Medication for Diabetes Industry Trends
2.3.2 Medication for Diabetes Market Drivers
2.3.3 Medication for Diabetes Market Challenges
2.3.4 Medication for Diabetes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medication for Diabetes Players by Revenue
3.1.1 Global Top Medication for Diabetes Players by Revenue (2019-2024)
3.1.2 Global Medication for Diabetes Revenue Market Share by Players (2019-2024)
3.2 Global Medication for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medication for Diabetes Revenue
3.4 Global Medication for Diabetes Market Concentration Ratio
3.4.1 Global Medication for Diabetes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication for Diabetes Revenue in 2023
3.5 Medication for Diabetes Key Players Head office and Area Served
3.6 Key Players Medication for Diabetes Product Solution and Service
3.7 Date of Enter into Medication for Diabetes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medication for Diabetes Breakdown Data by Type
4.1 Global Medication for Diabetes Historic Market Size by Type (2019-2024)
4.2 Global Medication for Diabetes Forecasted Market Size by Type (2025-2030)
5 Medication for Diabetes Breakdown Data by Application
5.1 Global Medication for Diabetes Historic Market Size by Application (2019-2024)
5.2 Global Medication for Diabetes Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Medication for Diabetes Market Size (2019-2030)
6.2 North America Medication for Diabetes Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Medication for Diabetes Market Size by Country (2019-2024)
6.4 North America Medication for Diabetes Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medication for Diabetes Market Size (2019-2030)
7.2 Europe Medication for Diabetes Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Medication for Diabetes Market Size by Country (2019-2024)
7.4 Europe Medication for Diabetes Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medication for Diabetes Market Size (2019-2030)
8.2 Asia-Pacific Medication for Diabetes Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Medication for Diabetes Market Size by Region (2019-2024)
8.4 Asia-Pacific Medication for Diabetes Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medication for Diabetes Market Size (2019-2030)
9.2 Latin America Medication for Diabetes Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Medication for Diabetes Market Size by Country (2019-2024)
9.4 Latin America Medication for Diabetes Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medication for Diabetes Market Size (2019-2030)
10.2 Middle East & Africa Medication for Diabetes Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Medication for Diabetes Market Size by Country (2019-2024)
10.4 Middle East & Africa Medication for Diabetes Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Tonghua Dongbao
11.1.1 Tonghua Dongbao Company Detail
11.1.2 Tonghua Dongbao Business Overview
11.1.3 Tonghua Dongbao Medication for Diabetes Introduction
11.1.4 Tonghua Dongbao Revenue in Medication for Diabetes Business (2019-2024)
11.1.5 Tonghua Dongbao Recent Development
11.2 Gan & Lee Pharmaceuticals
11.2.1 Gan & Lee Pharmaceuticals Company Detail
11.2.2 Gan & Lee Pharmaceuticals Business Overview
11.2.3 Gan & Lee Pharmaceuticals Medication for Diabetes Introduction
11.2.4 Gan & Lee Pharmaceuticals Revenue in Medication for Diabetes Business (2019-2024)
11.2.5 Gan & Lee Pharmaceuticals Recent Development
11.3 Shandong Lukang Pharmaceutical
11.3.1 Shandong Lukang Pharmaceutical Company Detail
11.3.2 Shandong Lukang Pharmaceutical Business Overview
11.3.3 Shandong Lukang Pharmaceutical Medication for Diabetes Introduction
11.3.4 Shandong Lukang Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024)
11.3.5 Shandong Lukang Pharmaceutical Recent Development
11.4 Otsuka Pharmaceutical
11.4.1 Otsuka Pharmaceutical Company Detail
11.4.2 Otsuka Pharmaceutical Business Overview
11.4.3 Otsuka Pharmaceutical Medication for Diabetes Introduction
11.4.4 Otsuka Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024)
11.4.5 Otsuka Pharmaceutical Recent Development
11.5 East China Pharmaceutical
11.5.1 East China Pharmaceutical Company Detail
11.5.2 East China Pharmaceutical Business Overview
11.5.3 East China Pharmaceutical Medication for Diabetes Introduction
11.5.4 East China Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024)
11.5.5 East China Pharmaceutical Recent Development
11.6 Beilu Pharmaceutical
11.6.1 Beilu Pharmaceutical Company Detail
11.6.2 Beilu Pharmaceutical Business Overview
11.6.3 Beilu Pharmaceutical Medication for Diabetes Introduction
11.6.4 Beilu Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024)
11.6.5 Beilu Pharmaceutical Recent Development
11.7 Furen Pharmaceutical
11.7.1 Furen Pharmaceutical Company Detail
11.7.2 Furen Pharmaceutical Business Overview
11.7.3 Furen Pharmaceutical Medication for Diabetes Introduction
11.7.4 Furen Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024)
11.7.5 Furen Pharmaceutical Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Medication for Diabetes Introduction
11.8.4 AstraZeneca Revenue in Medication for Diabetes Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Medication for Diabetes Introduction
11.9.4 Novartis Revenue in Medication for Diabetes Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Detail
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk Medication for Diabetes Introduction
11.10.4 Novo Nordisk Revenue in Medication for Diabetes Business (2019-2024)
11.10.5 Novo Nordisk Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Medication for Diabetes Introduction
11.11.4 Johnson & Johnson Revenue in Medication for Diabetes Business (2019-2024)
11.11.5 Johnson & Johnson Recent Development
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Company Detail
11.12.2 Boehringer Ingelheim Business Overview
11.12.3 Boehringer Ingelheim Medication for Diabetes Introduction
11.12.4 Boehringer Ingelheim Revenue in Medication for Diabetes Business (2019-2024)
11.12.5 Boehringer Ingelheim Recent Development
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Detail
11.13.2 Bristol-Myers Squibb Business Overview
11.13.3 Bristol-Myers Squibb Medication for Diabetes Introduction
11.13.4 Bristol-Myers Squibb Revenue in Medication for Diabetes Business (2019-2024)
11.13.5 Bristol-Myers Squibb Recent Development
11.14 Eli Lilly
11.14.1 Eli Lilly Company Detail
11.14.2 Eli Lilly Business Overview
11.14.3 Eli Lilly Medication for Diabetes Introduction
11.14.4 Eli Lilly Revenue in Medication for Diabetes Business (2019-2024)
11.14.5 Eli Lilly Recent Development
11.15 Merck
11.15.1 Merck Company Detail
11.15.2 Merck Business Overview
11.15.3 Merck Medication for Diabetes Introduction
11.15.4 Merck Revenue in Medication for Diabetes Business (2019-2024)
11.15.5 Merck Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Detail
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Medication for Diabetes Introduction
11.16.4 Sanofi Revenue in Medication for Diabetes Business (2019-2024)
11.16.5 Sanofi Recent Development
11.17 Pfizer
11.17.1 Pfizer Company Detail
11.17.2 Pfizer Business Overview
11.17.3 Pfizer Medication for Diabetes Introduction
11.17.4 Pfizer Revenue in Medication for Diabetes Business (2019-2024)
11.17.5 Pfizer Recent Development
11.18 Astellas Pharma
11.18.1 Astellas Pharma Company Detail
11.18.2 Astellas Pharma Business Overview
11.18.3 Astellas Pharma Medication for Diabetes Introduction
11.18.4 Astellas Pharma Revenue in Medication for Diabetes Business (2019-2024)
11.18.5 Astellas Pharma Recent Development
11.19 Daiichi Sankyo
11.19.1 Daiichi Sankyo Company Detail
11.19.2 Daiichi Sankyo Business Overview
11.19.3 Daiichi Sankyo Medication for Diabetes Introduction
11.19.4 Daiichi Sankyo Revenue in Medication for Diabetes Business (2019-2024)
11.19.5 Daiichi Sankyo Recent Development
11.20 Biocon
11.20.1 Biocon Company Detail
11.20.2 Biocon Business Overview
11.20.3 Biocon Medication for Diabetes Introduction
11.20.4 Biocon Revenue in Medication for Diabetes Business (2019-2024)
11.20.5 Biocon Recent Development
11.21 Glenmark
11.21.1 Glenmark Company Detail
11.21.2 Glenmark Business Overview
11.21.3 Glenmark Medication for Diabetes Introduction
11.21.4 Glenmark Revenue in Medication for Diabetes Business (2019-2024)
11.21.5 Glenmark Recent Development
11.22 Bayer AG
11.22.1 Bayer AG Company Detail
11.22.2 Bayer AG Business Overview
11.22.3 Bayer AG Medication for Diabetes Introduction
11.22.4 Bayer AG Revenue in Medication for Diabetes Business (2019-2024)
11.22.5 Bayer AG Recent Development
11.23 Takeda
11.23.1 Takeda Company Detail
11.23.2 Takeda Business Overview
11.23.3 Takeda Medication for Diabetes Introduction
11.23.4 Takeda Revenue in Medication for Diabetes Business (2019-2024)
11.23.5 Takeda Recent Development
11.24 Sun pharma
11.24.1 Sun pharma Company Detail
11.24.2 Sun pharma Business Overview
11.24.3 Sun pharma Medication for Diabetes Introduction
11.24.4 Sun pharma Revenue in Medication for Diabetes Business (2019-2024)
11.24.5 Sun pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Medication for Diabetes Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Biguanides
Table 3. Key Players of Sulfonylureas
Table 4. Key Players of Thiazolidinedione
Table 5. Key Players of α-Glucosidase Inhibitors
Table 6. Key Players of DPP-4 Inhibitors
Table 7. Key Players of GLP-1 Receptor Agonists
Table 8. Key Players of SGLT-2 Inhibitors
Table 9. Key Players of Insulins
Table 10. Global Medication for Diabetes Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Medication for Diabetes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Medication for Diabetes Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Medication for Diabetes Market Share by Region (2019-2024)
Table 14. Global Medication for Diabetes Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Medication for Diabetes Market Share by Region (2025-2030)
Table 16. Medication for Diabetes Market Trends
Table 17. Medication for Diabetes Market Drivers
Table 18. Medication for Diabetes Market Challenges
Table 19. Medication for Diabetes Market Restraints
Table 20. Global Medication for Diabetes Revenue by Players (2019-2024) & (US$ Million)
Table 21. Global Medication for Diabetes Market Share by Players (2019-2024)
Table 22. Global Top Medication for Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication for Diabetes as of 2023)
Table 23. Ranking of Global Top Medication for Diabetes Companies by Revenue (US$ Million) in 2023
Table 24. Global 5 Largest Players Market Share by Medication for Diabetes Revenue (CR5 and HHI) & (2019-2024)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Medication for Diabetes Product Solution and Service
Table 27. Date of Enter into Medication for Diabetes Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Medication for Diabetes Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global Medication for Diabetes Revenue Market Share by Type (2019-2024)
Table 31. Global Medication for Diabetes Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 32. Global Medication for Diabetes Revenue Market Share by Type (2025-2030)
Table 33. Global Medication for Diabetes Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global Medication for Diabetes Revenue Market Share by Application (2019-2024)
Table 35. Global Medication for Diabetes Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global Medication for Diabetes Revenue Market Share by Application (2025-2030)
Table 37. North America Medication for Diabetes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Medication for Diabetes Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Medication for Diabetes Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Medication for Diabetes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Europe Medication for Diabetes Market Size by Country (2019-2024) & (US$ Million)
Table 42. Europe Medication for Diabetes Market Size by Country (2025-2030) & (US$ Million)
Table 43. Asia-Pacific Medication for Diabetes Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 44. Asia-Pacific Medication for Diabetes Market Size by Region (2019-2024) & (US$ Million)
Table 45. Asia-Pacific Medication for Diabetes Market Size by Region (2025-2030) & (US$ Million)
Table 46. Latin America Medication for Diabetes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Latin America Medication for Diabetes Market Size by Country (2019-2024) & (US$ Million)
Table 48. Latin America Medication for Diabetes Market Size by Country (2025-2030) & (US$ Million)
Table 49. Middle East & Africa Medication for Diabetes Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 50. Middle East & Africa Medication for Diabetes Market Size by Country (2019-2024) & (US$ Million)
Table 51. Middle East & Africa Medication for Diabetes Market Size by Country (2025-2030) & (US$ Million)
Table 52. Tonghua Dongbao Company Detail
Table 53. Tonghua Dongbao Business Overview
Table 54. Tonghua Dongbao Medication for Diabetes Product
Table 55. Tonghua Dongbao Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 56. Tonghua Dongbao Recent Development
Table 57. Gan & Lee Pharmaceuticals Company Detail
Table 58. Gan & Lee Pharmaceuticals Business Overview
Table 59. Gan & Lee Pharmaceuticals Medication for Diabetes Product
Table 60. Gan & Lee Pharmaceuticals Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 61. Gan & Lee Pharmaceuticals Recent Development
Table 62. Shandong Lukang Pharmaceutical Company Detail
Table 63. Shandong Lukang Pharmaceutical Business Overview
Table 64. Shandong Lukang Pharmaceutical Medication for Diabetes Product
Table 65. Shandong Lukang Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 66. Shandong Lukang Pharmaceutical Recent Development
Table 67. Otsuka Pharmaceutical Company Detail
Table 68. Otsuka Pharmaceutical Business Overview
Table 69. Otsuka Pharmaceutical Medication for Diabetes Product
Table 70. Otsuka Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 71. Otsuka Pharmaceutical Recent Development
Table 72. East China Pharmaceutical Company Detail
Table 73. East China Pharmaceutical Business Overview
Table 74. East China Pharmaceutical Medication for Diabetes Product
Table 75. East China Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 76. East China Pharmaceutical Recent Development
Table 77. Beilu Pharmaceutical Company Detail
Table 78. Beilu Pharmaceutical Business Overview
Table 79. Beilu Pharmaceutical Medication for Diabetes Product
Table 80. Beilu Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 81. Beilu Pharmaceutical Recent Development
Table 82. Furen Pharmaceutical Company Detail
Table 83. Furen Pharmaceutical Business Overview
Table 84. Furen Pharmaceutical Medication for Diabetes Product
Table 85. Furen Pharmaceutical Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 86. Furen Pharmaceutical Recent Development
Table 87. AstraZeneca Company Detail
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Medication for Diabetes Product
Table 90. AstraZeneca Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Novartis Company Detail
Table 93. Novartis Business Overview
Table 94. Novartis Medication for Diabetes Product
Table 95. Novartis Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Novo Nordisk Company Detail
Table 98. Novo Nordisk Business Overview
Table 99. Novo Nordisk Medication for Diabetes Product
Table 100. Novo Nordisk Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 101. Novo Nordisk Recent Development
Table 102. Johnson & Johnson Company Detail
Table 103. Johnson & Johnson Business Overview
Table 104. Johnson & Johnson Medication for Diabetes Product
Table 105. Johnson & Johnson Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 106. Johnson & Johnson Recent Development
Table 107. Boehringer Ingelheim Company Detail
Table 108. Boehringer Ingelheim Business Overview
Table 109. Boehringer Ingelheim Medication for Diabetes Product
Table 110. Boehringer Ingelheim Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 111. Boehringer Ingelheim Recent Development
Table 112. Bristol-Myers Squibb Company Detail
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Medication for Diabetes Product
Table 115. Bristol-Myers Squibb Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Eli Lilly Company Detail
Table 118. Eli Lilly Business Overview
Table 119. Eli Lilly Medication for Diabetes Product
Table 120. Eli Lilly Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 121. Eli Lilly Recent Development
Table 122. Merck Company Detail
Table 123. Merck Business Overview
Table 124. Merck Medication for Diabetes Product
Table 125. Merck Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 126. Merck Recent Development
Table 127. Sanofi Company Detail
Table 128. Sanofi Business Overview
Table 129. Sanofi Medication for Diabetes Product
Table 130. Sanofi Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 131. Sanofi Recent Development
Table 132. Pfizer Company Detail
Table 133. Pfizer Business Overview
Table 134. Pfizer Medication for Diabetes Product
Table 135. Pfizer Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 136. Pfizer Recent Development
Table 137. Astellas Pharma Company Detail
Table 138. Astellas Pharma Business Overview
Table 139. Astellas Pharma Medication for Diabetes Product
Table 140. Astellas Pharma Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 141. Astellas Pharma Recent Development
Table 142. Daiichi Sankyo Company Detail
Table 143. Daiichi Sankyo Business Overview
Table 144. Daiichi Sankyo Medication for Diabetes Product
Table 145. Daiichi Sankyo Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 146. Daiichi Sankyo Recent Development
Table 147. Biocon Company Detail
Table 148. Biocon Business Overview
Table 149. Biocon Medication for Diabetes Product
Table 150. Biocon Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 151. Biocon Recent Development
Table 152. Glenmark Company Detail
Table 153. Glenmark Business Overview
Table 154. Glenmark Medication for Diabetes Product
Table 155. Glenmark Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 156. Glenmark Recent Development
Table 157. Bayer AG Company Detail
Table 158. Bayer AG Business Overview
Table 159. Bayer AG Medication for Diabetes Product
Table 160. Bayer AG Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 161. Bayer AG Recent Development
Table 162. Takeda Company Detail
Table 163. Takeda Business Overview
Table 164. Takeda Medication for Diabetes Product
Table 165. Takeda Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 166. Takeda Recent Development
Table 167. Sun pharma Company Detail
Table 168. Sun pharma Business Overview
Table 169. Sun pharma Medication for Diabetes Product
Table 170. Sun pharma Revenue in Medication for Diabetes Business (2019-2024) & (US$ Million)
Table 171. Sun pharma Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medication for Diabetes Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Medication for Diabetes Market Share by Type: 2023 VS 2030
Figure 3. Biguanides Features
Figure 4. Sulfonylureas Features
Figure 5. Thiazolidinedione Features
Figure 6. α-Glucosidase Inhibitors Features
Figure 7. DPP-4 Inhibitors Features
Figure 8. GLP-1 Receptor Agonists Features
Figure 9. SGLT-2 Inhibitors Features
Figure 10. Insulins Features
Figure 11. Global Medication for Diabetes Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Medication for Diabetes Market Share by Application: 2023 VS 2030
Figure 13. Type 1 Diabetes Treatment Case Studies
Figure 14. Type 2 Diabetes Treatment Case Studies
Figure 15. Medication for Diabetes Report Years Considered
Figure 16. Global Medication for Diabetes Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Medication for Diabetes Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Medication for Diabetes Market Share by Region: 2023 VS 2030
Figure 19. Global Medication for Diabetes Market Share by Players in 2023
Figure 20. Global Top Medication for Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication for Diabetes as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Medication for Diabetes Revenue in 2023
Figure 22. North America Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Medication for Diabetes Market Share by Country (2019-2030)
Figure 24. United States Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Medication for Diabetes Market Share by Country (2019-2030)
Figure 28. Germany Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Medication for Diabetes Market Share by Region (2019-2030)
Figure 36. China Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Medication for Diabetes Market Share by Country (2019-2030)
Figure 44. Mexico Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Medication for Diabetes Market Share by Country (2019-2030)
Figure 48. Turkey Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Medication for Diabetes Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Tonghua Dongbao Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 51. Gan & Lee Pharmaceuticals Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 52. Shandong Lukang Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 53. Otsuka Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 54. East China Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 55. Beilu Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 56. Furen Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 58. Novartis Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 59. Novo Nordisk Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 63. Eli Lilly Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 64. Merck Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 65. Sanofi Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 66. Pfizer Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 67. Astellas Pharma Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 68. Daiichi Sankyo Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 69. Biocon Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 70. Glenmark Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 71. Bayer AG Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 72. Takeda Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 73. Sun pharma Revenue Growth Rate in Medication for Diabetes Business (2019-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock